CMC Sections of Regulatory Filings and CMC Regulatory Compliance during Investigational and Postapproval Stages
Bibliographic record
Abstract
Introduction ....................................................................................................... 200 Pharmaceutical Quality ..................................................................................... 200 Drug Substance ............................................................................................ 201 Manufacture ................................................................................................. 202 Characterization (Structure Elucidation)...................................................... 204 Control of Drug Substance (Specifications) ................................................. 205 Reference Standards or Materials ................................................................ 206 Container Closure System ............................................................................ 206 Stability ........................................................................................................ 207 Drug Product ............................................................................................... 207 Description and Composition of the Drug Product ................................. 207 Pharmaceutical Development .................................................................. 207 Components of the Drug Product ............................................................ 208 Drug Product Development ..................................................................... 208 Manufacture (Manufacturer(s)/Method of Manufacture) .............................210 Control of Excipients (Specifications) ..........................................................211 Control of Drug Product (Specifications) .....................................................211 Justification of Specification(s) .....................................................................214 Reference Standards or Materials .................................................................214 Container Closure System .............................................................................214 Stability ........................................................................................................ 215 The chemistry, manufacturing, and controls (CMC) section of a regulatory filing [investigational new drug (IND), IND amendments, IND annual reports, new drug application (NDA) or biologics license application (BLA), postapproval CMC supplements, and NDA annual reports] contains detailed information pertaining to the characteristics, manufacturing, and quality aspects of the drug substance and drug product. Under the International Conference on Harmonization (ICH) Common Technical Document (CTD) format,1 the CMC section is referred to as the quality section and the structure is outlined in the ICH CTD guidance.2 This chapter first discusses the details of the quality section of a CTD, followed by how CMC changes are managed during the IND development phases and postapproval stages. As this book addresses the Food and Drug Administration (FDA) regulatory affairs, the focus of the discussions is primarily based on the US FDA expectations and requirements. Other health authority requirements such as those found in Europe, Canada, Japan, or China could vary significantly from this chapter with respect to CMC, and the reader is encouraged to seek other reference materials as appropriate.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.002 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".